ACE inhibitors: A novel treatment for neurofibroma

Annals of Surgical Oncology

Volumn 15, Issue 5, 2008, Pages 1538-1539

  Namazi, Hamid ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; DOWN REGULATION; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; LETTER; MAST CELL; NEUROFIBROMA; PROTEIN PHOSPHORYLATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HUMANS; NEUROFIBROMA;

EID: 41549162542     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9737-5     Document Type: Letter

References (10)

1. Rutkowski JL, Wu K, Gutmann DH, et al. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet 2000;9:1059-66
2. Coussens LM, Werb Z. Inflammatory cells and cancer: think different. J Exp Med 2001;193:23-6
3. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004;432:332-7
4. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7
5. Rubin JB, Gutmann DH. Neurofibromatosis type 1-a model for nervous system tumour formation? Nat Rev Cancer 2005;5:557-64
6. Peng H, Carretero OA, Raij L, et al. Anti-fibrotic effects of N-acetyl-seryl-aspartyl-lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats. Hypertension 2001;37:794-800
7. Campbell SE, Katwa LC. Angiotensin II stimulated expression of transforming growth factor-β1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol 1997;29:1947-58
8. Chen MM, Lam A, Abraham JA, et al. CTGF expression is induced by TGF-β in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 2000;32:1805-19
9. Hitoshi Y, Ryuichi N, Hideyuki K, et al. Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C. World J Gastroenterol 2006;12:6786-91
10. Wrana JL, Attisano L, Wieser R, et al. Mechanism of activation of the TGF-β receptor. Nature 1994;370:341-7